High bias gas flows increase lung injury in the ventilated preterm lamb

PLoS One. 2012;7(10):e47044. doi: 10.1371/journal.pone.0047044. Epub 2012 Oct 8.

Abstract

Background: Mechanical ventilation of preterm babies increases survival but can also cause ventilator-induced lung injury (VILI), leading to the development of bronchopulmonary dysplasia (BPD). It is not known whether shear stress injury from gases flowing into the preterm lung during ventilation contributes to VILI.

Methods: Preterm lambs of 131 days' gestation (term = 147 d) were ventilated for 2 hours with a bias gas flow of 8 L/min (n = 13), 18 L/min (n = 12) or 28 L/min (n = 14). Physiological parameters were measured continuously and lung injury was assessed by measuring mRNA expression of early injury response genes and by histological analysis. Control lung tissue was collected from unventilated age-matched fetuses. Data were analysed by ANOVA with a Tukey post-hoc test when appropriate.

Results: High bias gas flows resulted in higher ventilator pressures, shorter inflation times and decreased ventilator efficiency. The rate of rise of inspiratory gas flow was greatest, and pulmonary mRNA levels of the injury markers, EGR1 and CTGF, were highest in lambs ventilated with bias gas flows of 18 L/min. High bias gas flows resulted in increased cellular proliferation and abnormal deposition of elastin, collagen and myofibroblasts in the lung.

Conclusions: High ventilator bias gas flows resulted in increased lung injury, with up-regulation of acute early response genes and increased histological lung injury. Bias gas flows may, therefore, contribute to VILI and BPD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Bronchopulmonary Dysplasia / etiology*
  • Bronchopulmonary Dysplasia / metabolism
  • Humans
  • Infant, Newborn
  • Sheep
  • Stress, Mechanical
  • Ventilator-Induced Lung Injury / etiology*
  • Ventilator-Induced Lung Injury / metabolism

Grants and funding

The authors thank the Auckland Medical Research Foundation (grant number 81502, http://www.medicalresearch.co.nz/), the Health Research Council of New Zealand (grant number 06/082; http://www.hrc.govt.nz/), the National Research Centre for Growth and Development in New Zealand (grant number (grant number 06018FB; http://www.nrcgd.org.nz/), and the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.